STOCK Bcorflox/Cnrm

Status

Available to order

EMMA IDEM:15104
Citation informationRRID:IMSR_EM:15104 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameSTOCK Bcorflox/Cnrm
Alternative nameC57/BL6 BCOR floxed
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolBcorflox
Gene/Transgene symbolBcor

Information from provider

ProviderPaolo Sportoletti
Provider affiliationMedicina e Chirurgia, Università Degli Studi Di Perugia
Genetic informationBcor conditional knock-out targeted mutation (floxed exons 8-10). This mutation leads to mRNA degradation or to the translation of a non-functional protein. To study the effects of Bcor loss on hematopoietic cells, we crossed the Bcor floxed (exons 8-10) mice with mice that express the cre recombinase under the control of an inducible Mx1 promoter. The expression of Mx1-cre and excision of PGK-neo cassette were induced by poly-inosinicpolycytidylic acid (pIpC) treatment in vivo: 8- to 12 -week-old mice were injected intraperitoneally with 250 mg/dose pIpC every other day for 3 injections. Mice were analyzed starting 2 months after pIpC induction.
Phenotypic informationHomozygous:
To study the effects of Bcor gene loss in the murine hematopoietic system, we crossed Bcor floxed mice with mice expressing the cre recombinase under the control of an inducible Mx1 promoter. In homozygous Bcor knock-out mice, we then performed serial complete blood counts that showed leukopenia (mainly due to B-cell lymphopenia), red blood cells' (RBC) reduction with increased mean corpuscle volume (MCV), and platelet count's progressive increase. Resulting thrombocytosis derived from the accumulation of both megakaryocytic-erythroid (MEP, Lin/Sca1/Kit+CD34FCyRII/IIIlo/) and megakaryocytic progenitors (MkPs, Lin-,c-Kit+,Sca1-,CD150+,CD41+) relied on a decrease of apoptosis within bone marrow cavity. The impact of Bcor loss on survival for an extended period (18 months) showed low survival rate of Bcor null mice, and post-mortem pathological examinations did not reveal any leukemia infiltration in hematopoietic organs. Taken together, these data confirmed that Bcor loss negatively influences mice survival by specifically subverting normal hematopoietic compartments and PB output.

Heterozygous:
Heterozygous mice lacking Bcor (Bcor+/-) show a similar, but less penetrant, phenotype as the homozygous knock-out mice.
Breeding history.
References
  • Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.;Sportoletti Paolo, Sorcini Daniele, Guzman Anna G, Reyes Jaime M, Stella Arianna, Marra Andrea, Sartori Sara, Brunetti Lorenzo, Rossi Roberta, Papa Beatrice Del, Adamo Francesco Maria, Pianigiani Giulia, Betti Camilla, Scialdone Annarita, Guarente Valerio, Spinozzi Giulio, Tini Valentina, Martelli Maria Paola, Goodell Margaret A, Falini Brunangelo, ;2021;Leukemia;35;1949-1963; 33159179
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedyes

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice.;Sportoletti Paolo, Sorcini Daniele, Guzman Anna G, Reyes Jaime M, Stella Arianna, Marra Andrea, Sartori Sara, Brunetti Lorenzo, Rossi Roberta, Papa Beatrice Del, Adamo Francesco Maria, Pianigiani Giulia, Betti Camilla, Scialdone Annarita, Guarente Valerio, Spinozzi Giulio, Tini Valentina, Martelli Maria Paola, Goodell Margaret A, Falini Brunangelo, ;2021;Leukemia;35;1949-1963; 33159179

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).